ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,555.74
      -0.16%
      US Tech 100
      19,126.44
      -0.86%
      Dow Jones
      40,358.09
      -0.14%
      Brent Oil
      80.775
      -0.91%
      Bitcoin
      65,993.85
      -2.38%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Iovance Biotherapeutics Inc (IOVA)

      7. Iovance Biotherapeutics Inc (IOVA) Financials

      Iovance Biotherapeutics Inc

      Iovance Biotherapeutics Inc (IOVA)

      NASDAQ
      8.69
      0.36
      (4.32%)
      At close: July 23 4:00PM
      Delayed by 15 minutes
      8.73
      0.04
      ( 0.46% )
      After Hours: 6:36PM
      Delayed by 15 minutes

      Iovance Biotherapeutics Inc Financial Summary

      The current IOVA market cap is 2.44B. The company's latest EPS is USD -1.5868 and P/E is -5.47.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 0238k469k482k715k
      Operating Income -110.86M-110.09M-118.36M-121.26M-117.72M
      Net Income -107.37M-106.53M-113.76M-116.38M-112.98M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00001.19M
      Operating Income -206.87M-261.94M-342.7M-398.88M-460.56M
      Net Income -197.56M-259.58M-342.25M-395.89M-444.04M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 824.77M757.29M852.32M780.35M869.83M
      Total Liabilities 157.89M178.72M178.31M195.74M189.81M
      Total Equity 666.88M578.57M674.01M584.61M680.02M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 344.66M768.46M777.33M663.98M780.35M
      Total Liabilities 45.68M111.96M155.67M164.34M195.74M
      Total Equity 298.97M656.5M621.66M499.64M584.61M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -99.82M-193.77M-277.85M-361.82M-122.28M
      Investing 153.4M-3.38M-82.4M-155.24M-111.51M
      Financing 258.17M259.2M462M462.96M193.58M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -158.89M-205.13M-227.94M-292.76M-361.82M
      Investing 90.03M-317.85M132k256.46M-155.24M
      Financing 6.13M576.42M239.27M190.15M462.96M

      Stats and Ratios

      Market Cap 2.44B
      Price to Earnings Ratio -5.47
      Price to Sales Ratio 2.07k
      Price to Cash Ratio 21.14
      Price to Book Ratio 4.15
      Dividend Yield -

      Share Statistics

      Shares Outstanding 279.83M
      Average Volume (1 week) 5.34M
      Average Volume (1 Month) 6.74M
      52 Week Change 14.57%
      52 Week High 18.33
      52 Week Low 3.21
      Spread (Intraday) 0.03 (0.34%)

      Company Info

      Company Name Iovance Biotherapeutics Inc
      Address 2140 s dupont hwy
      camden, delaware 19934
      Website https://www.iovance.com
      Industry biological pds,ex diagnstics (2836)